A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0e25276be7f4139860cffdfc046439d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d0e25276be7f4139860cffdfc046439d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d0e25276be7f4139860cffdfc046439d2021-12-02T17:37:13ZA nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis10.1038/s41467-021-25990-w2041-1723https://doaj.org/article/d0e25276be7f4139860cffdfc046439d2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25990-whttps://doaj.org/toc/2041-1723PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.Guohao WangLisi XieBei LiWei SangJie YanJie LiHao TianWenxi LiZhan ZhangYe TianYunlu DaiNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Guohao Wang Lisi Xie Bei Li Wei Sang Jie Yan Jie Li Hao Tian Wenxi Li Zhan Zhang Ye Tian Yunlu Dai A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis |
description |
PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy. |
format |
article |
author |
Guohao Wang Lisi Xie Bei Li Wei Sang Jie Yan Jie Li Hao Tian Wenxi Li Zhan Zhang Ye Tian Yunlu Dai |
author_facet |
Guohao Wang Lisi Xie Bei Li Wei Sang Jie Yan Jie Li Hao Tian Wenxi Li Zhan Zhang Ye Tian Yunlu Dai |
author_sort |
Guohao Wang |
title |
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis |
title_short |
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis |
title_full |
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis |
title_fullStr |
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis |
title_full_unstemmed |
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis |
title_sort |
nanounit strategy reverses immune suppression of exosomal pd-l1 and is associated with enhanced ferroptosis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/d0e25276be7f4139860cffdfc046439d |
work_keys_str_mv |
AT guohaowang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT lisixie ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT beili ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT weisang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT jieyan ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT jieli ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT haotian ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT wenxili ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT zhanzhang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT yetian ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT yunludai ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT guohaowang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT lisixie nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT beili nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT weisang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT jieyan nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT jieli nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT haotian nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT wenxili nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT zhanzhang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT yetian nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis AT yunludai nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis |
_version_ |
1718379910415777792 |